PDUFA Clock Ticks For FDA Decision On First OTC Acne Ingredient NDA
This article was originally published in The Tan Sheet
Executive Summary
Under PDUFA timelines for supplemental NDAs, FDA has until sometime in June to make a decision on Galderma Labs' application, or to state that it will need more time before announcing its conclusion.